By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck Serono 

9, chemin des Mines
Case postale 54
Geneva    CH-1211  Switzerland
Phone: 41-22-414-3000 Fax: 41-22-731-2179



Company News
Merck Serono As Pioneer In Assisted Reproductive Treatments Takes Leading Role In Fertility Technologies Signing A Global Collaboration Agreement With Genea Biomedx 5/28/2015 6:55:05 AM
CytoTools Appoints Dr. RĂ¼diger Weseloh Of Merck Serono To Its Advisory Board 5/26/2015 10:05:48 AM
Alise Reicin Joins Merck Serono As Head Of Global Clinical Development 4/16/2015 12:55:20 PM
Merck Serono, Intrexon Corporation Ink $941M Pact, As Race for CAR-T Edge Continues 3/30/2015 10:03:41 AM
Intrexon Corporation And Merck Serono Announce Agreement For The Development And Commercialization Of CAR-T Therapy 3/30/2015 6:59:57 AM
Illumina (ILMN) Announces Strategic Collaboration With Merck Serono To Expand Companion Diagnostics For Oncology 3/10/2015 8:26:44 AM
Opexa Therapeutics (OPXA) Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna For Multiple Sclerosis 3/9/2015 11:21:37 AM
Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs 10/7/2014 6:01:16 AM
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014 5:54:01 AM
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014 6:38:13 AM